Marimed (MRMD) Invested Capital (2013 - 2026)

Marimed (MRMD) has 14 years of Invested Capital data on file, last reported at $3.5 million in Q1 2026.

• On a quarterly basis, Invested Capital fell 10.25% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $15.6 million, a 4.08% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, up 2.64% from the prior year.
• Invested Capital for Q1 2026 stood at $3.5 million, down from $4.0 million in the prior quarter.
• Over the last five years, Invested Capital for MRMD reached as high as $4.4 million in Q3 2025 and fell as low as $518000.0 in Q2 2022.
• Historically, Invested Capital has averaged $2.8 million across 5 years, with a median of $3.5 million in 2026.
• Across the five-year window, Invested Capital soared 1283.68% in 2022 and slipped 13.67% in 2025, its largest moves.
• Year by year, Invested Capital stood at $686000.0 in 2022, then surged by 388.34% to $3.4 million in 2023, then rose by 17.73% to $3.9 million in 2024, then grew by 2.64% to $4.0 million in 2025, then fell by 13.44% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $3.5 million in Q1 2026, $4.0 million in Q4 2025, and $4.4 million in Q3 2025.